Actively Recruiting
Enabling People with Diabetic Neuropathy to Drive Safely: a Proof of Concept Randomised Controlled Trial
Led by Manchester Metropolitan University · Updated on 2024-12-18
115
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a visual feedback intervention to improve how people with diabetic peripheral neuropathy (DPN) use the accelerator pedal while driving. This proof-of-concept randomized controlled trial aims to see if giving visual warnings during simulated driving reduces the time drivers spend pressing the accelerator more than halfway down. The study also compares drivers with DPN who receive the intervention or no feedback, and includes a group with diabetes but no neuropathy for comparison. Participants will attend up to six visits one month apart at a driving simulator. Those with DPN who press the accelerator beyond 9 degrees in the initial assessment will be randomly assigned to receive visual feedback training or no feedback. Drivers in the intervention group will experience a warning symbol when pressing the accelerator too far, meant to help them moderate pedal use. Control group drivers have three visits to assess driving without feedback. Drivers without neuropathy have one assessment visit only. During visits, participants undergo driving simulator tests including practice drives, baseline assessments, and drives with or without visual feedback. Additional tests at the first visit include peripheral neuropathy assessments, proprioception measurement, blood glucose testing, and collection of demographic and driving history information. Researchers measure outcomes such as the percentage of time the accelerator is pressed beyond the threshold and vehicle control. Participant feedback is collected after the final visit to improve the program. The total study duration extends up to six months for intervention participants.
CONDITIONS
Brief Title
Driving with Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to understand English and provide informed consent
- Current full UK driving licence held for at least 5 years
- Drives a car at least once per week
- Diagnosed with type 2 diabetes and diabetic peripheral neuropathy
- Diagnosed with type 2 diabetes only (no diagnosed diabetic peripheral neuropathy)
You will not qualify if you...
- Active foot ulcer on either foot
- Lower limb amputation involving more than two toes on the right foot
- Dementia
- Participating in another research study that may affect safety or scientific integrity, such as a pharmaceutical trial affecting driving ability
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo a baseline driving assessment including practice and assessment drives, neuropathy and proprioception testing, blood glucose testing, and demographic data collection. Participants with diabetic peripheral neuropathy (DPN) who meet criteria are randomized to intervention or control groups.
1 visit (in-person)
Duration - 6 months with monthly visits
Participants with DPN in the intervention group receive visual feedback training during simulated driving sessions to reduce excessive use of the accelerator pedal. Each session includes multiple driving tasks with and without feedback.
6 visits (in-person), approximately 1 month apart
Duration - 6 months with visits timed to intervention group
Participants with DPN in the control group complete simulated driving assessments without visual feedback to match the timing of the intervention group's visits.
3 visits (in-person), timed to match visits 1, 3, and 6 of the intervention group
Duration - 1 day
Participants with diabetes but no diagnosed neuropathy complete a single visit with simulated driving assessment and baseline testing without intervention.
1 visit (in-person)
Duration - At the final visit
At the final visit, participants provide feedback on their experience of the driving simulator sessions and visual feedback training if applicable.
1 visit (in-person) at last session
Trial Site Locations
Total: 1 location
1
Manchester Metropolitan University
Manchester, United Kingdom
Actively Recruiting
Research Team
M
Maaike Esselaar, PhD
D
Dilwyn Marple-Horvat, DPhil
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here